Peer-Reviewed Aging Research Journal | Aging-US (original) (raw)

MISSION & AIMS

Aging-US is dedicated to advancing our understanding of the biological mechanisms that drive aging and the development of age-related diseases. Our mission is to serve as a platform for high-quality research that uncovers the cellular, molecular, and systemic processes underlying aging, and translates these insights into strategies to extend healthspan and delay the onset of chronic disease.

We aim to promote:

  1. The treatment of age-related diseases through interventions that target the aging process itself.
  2. The validation of anti-aging therapies by demonstrating their impact on functional decline and disease onset.
  3. The development of preventative strategies that delay or mitigate age-associated pathologies by modulating key aging mechanisms.

Aging-US actively welcomes studies that utilize innovative technologies, novel model systems, and early-phase clinical trials to accelerate the translation of aging research into meaningful interventions. By bridging fundamental biology with clinical application, the journal supports a paradigm shift from disease treatment to healthspan preservation.

ARCHIVING & INDEXING

Acknowledgment of 2025 Reviewers

Aging-US sincerely thanks all reviewers who contributed their expertise and time during 2025.

Rigorous and constructive peer review is essential to scientific progress. Through their careful evaluations, our reviewers played a central role in maintaining the scientific quality, integrity, and credibility of the journal...

-Marco Demaria
Editor-in-Chief, Aging-US

Statement From Our Editor-In-Chief

Dr. Marco Demaria

As of January 1, 2026, Aging has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.